the neurochemical effect of tetrabenazine was assessed by determining the levels of dopamine , noradrenaline and 5-hydroxytryptamine and their metabolites in post-mortem brain from huntington 's disease patients with or without a history of tetrabenazine treatment .
C0020179
huntington 's disease
C0039623
tetrabenazine